Release Date: November 20, 2022
The U.S. Department of Homeland Security has recently approved research to use artificial intelligence to look at drug supply chain and investigate weaknesses. Quantifind Inc. will do the work, looking into supply chains for the Cross-Border Threat Screening and Supply Chain Defense Center of Excellence (CBTS). Part of the investigation will be to look at the foreign influence on U.S. drug supplies and see what drugs may be susceptible to disruption;
To read the full article, click the button below.